18 results on '"Mitra, Debarpan"'
Search Results
2. Hypericum roeperianum bark extract suppresses breast cancer proliferation via induction of apoptosis, downregulation of PI3K/Akt/mTOR signaling cascade and reversal of EMT
- Author
-
Guefack, Michel-Gael F., Talukdar, Debojit, Mukherjee, Rimi, Guha, Subhabrata, Mitra, Debarpan, Saha, Depanwita, Das, Gaurav, Damen, François, Kuete, Victor, and Murmu, Nabendu
- Published
- 2024
- Full Text
- View/download PDF
3. Lupeol synergizes with 5-fluorouracil to combat c-MET/EphA2 mediated chemoresistance in triple negative breast cancer
- Author
-
Mitra, Debarpan, Saha, Depanwita, Das, Gaurav, Mukherjee, Rimi, Banerjee, Samir, Alam, Neyaz, Mustafi, Saunak Mitra, Nath, Partha, Majumder, Anuj, Majumder, Biswanath, and Murmu, Nabendu
- Published
- 2023
- Full Text
- View/download PDF
4. Lupeol and Paclitaxel cooperate in hindering hypoxia induced vasculogenic mimicry via suppression of HIF-1α-EphA2-Laminin-5γ2 network in human oral cancer
- Author
-
Saha, Depanwita, Mitra, Debarpan, Alam, Neyaz, Sen, Sagar, Mustafi, Saunak Mitra, Majumder, Pradip K., Majumder, Biswanath, and Murmu, Nabendu
- Published
- 2022
- Full Text
- View/download PDF
5. High anticancer activity in short response time exhibited by a new azobenzene derivative and its copper complex.
- Author
-
Dev, Samrat, Mitra, Debarpan, Sinha, Chittaranjan, Das, Gaurav, Murmu, Nabendu, Maity, Amit Ranjan, and Pandey, Souvik
- Subjects
- *
AZOBENZENE derivatives , *DIMETHYL sulfoxide , *COPPER compounds , *ANTINEOPLASTIC agents , *COPPER , *NUCLEAR fragmentation - Abstract
o‐Aminoazotoluene (OAT), capable of photoisomerization, and o‐vanillin, a potent comutagen, have been used to synthesize a new ligand, HL, [C6H4(CH3)N=NC6H3(CH3)N=CHC6H3(OH)(OCH3)], which, upon complexation with copper(II), results in a new copper(II) complex‐Cu(L)2, [Cu{C6H4(CH3)N=NC6H3(CH3)N=CHC6H3(OCH3)O}2]. Both HL and Cu(L)2 have been characterized by single‐crystal X‐ray diffraction measurements along with other analytical techniques, for example, IR spectroscopy, NMR spectroscopy, UV–Vis spectroscopy, elemental analysis and mass spectrometry. These compounds were tested with different in vitro anticancer assay as well as with in silico studies. A comparative study has been demonstrated on anticancer activity of HL and Cu(L)2 with the ligand HAZ, {C6H5N=NC6H4N=CHC6H3(OH)(OCH3)} and its Cu‐complex, [Cu(AZ)2, Cu{C6H5N=NC6H4N=CHC6H3(OCH3)O}2]. The sensing properties of HAZ, along with the synthesis and structural properties of both HAZ and Cu(AZ)2, have been reported by our group earlier. Cytotoxicity measurements on MCF7 cell lines show that Cu(L)2 and Cu(AZ)2 have higher anticancer activity than their corresponding ligands. The apoptotic effect of Cu‐complex was studied through nuclear fragmentation assay and AO/EB dual‐staining assay on MCF7 cell line. The IC50 value of Cu(L)2 in 0.01% DMSO/water after 24‐h treatment was found 4.2 μM, which is one of the lowest values with this response time compared to the other analogous anticancer compounds. Finally, we have evaluated the expression of hERα protein with respect to Cu‐complexes, and it was observed that Cu(L)2 caused more down‐regulation of hERα as compared to Cu(AZ)2. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast
- Author
-
Mitra, Debarpan, Bhattacharyya, Sayantan, Alam, Neyaz, Sen, Sagar, Mitra, Saunak, Mandal, Syamsundar, Vignesh, Shivani, Majumder, Biswanath, and Murmu, Nabendu
- Published
- 2020
- Full Text
- View/download PDF
7. Reversing effect of Lupeol on vasculogenic mimicry in murine melanoma progression
- Author
-
Bhattacharyya, Sayantan, Mitra, Debarpan, Ray, Sudipta, Biswas, Nirjhar, Banerjee, Samir, Majumder, Biswanath, Mustafi, Saunak Mitra, and Murmu, Nabendu
- Published
- 2019
- Full Text
- View/download PDF
8. Fabrication of a New Coumarin Based Fluorescent "turn-on" Probe for Distinct and Sequential Recognition of Al3+ and F− Along With Its Application in Live Cell Imaging.
- Author
-
Maji, Atanu, Naskar, Rahul, Mitra, Debarpan, Gharami, Saswati, Murmu, Nabendu, and Mondal, Tapan Kumar
- Subjects
BINDING constant ,DETECTION limit ,ALUMINUM foam ,CANCER cells ,BREAST cancer ,BREAST imaging - Abstract
A new coumarin based fluorescent switch PCEH is fabricated which displays high selective sensing towards Al
3+ among other metal cations at physiological pH. On gradual addition of Al3+ , PCEH shows a brilliant "turn-on" emission enhancement in MeOH/H2 O (4/1, v/v) solution. This new fluorescent switch is proven to be a reversible probe by gradual addition of F− into the PCEH-Al3+ solution. Detection limit as well as binding constant values are calculated to be in the order of 10–9 M and 104 M−1 respectively. We have also explored its potential as a biomarker in the application of live cell imaging using breast cancer cells (MDA-MB-231 cell). [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
9. Lupeol and Paclitaxel cooperate in hindering hypoxia induced vasculogenic mimicry via suppression of HIF-1α-EphA2-Laminin-5γ2 network in human oral cancer.
- Author
-
Saha, Depanwita, Mitra, Debarpan, Alam, Neyaz, Sen, Sagar, Mustafi, Saunak Mitra, Majumder, Pradip K., Majumder, Biswanath, and Murmu, Nabendu
- Abstract
Vasculogenic mimicry (VM), defined as an endothelial cell independent alternative mechanism of blood and nutrient supply by dysregulated tumor cells, is associated with poor prognosis in oral squamous cell carcinoma (OSCC). Here we aim to investigate the underlying molecular mechanism of the synergistic effect of phytochemical Lupeol and standard microtubule inhibitor Paclitaxel in reversing the hypoxia induced VM formation in OSCC. The results demonstrated that the hypoxia induced upregulation of HIF-1α led to augmentation of signaling cascade associated with extracellular matrix remodeling and EMT phenotypes that are mechanistically linked to VM. Induction of HIF-1α altered the expression of EMT/CSC markers (E-Cadherin, Vimentin, Snail, Twist and CD133) and enhanced the ability of cell migration/invasion and spheroid formation. Subsequently, the targeted knockdown of HIF-1α by siRNA led to the perturbation of matrigel mediated tube formation as well as of Laminin-5γ2 expression with the down-regulation of VE-Cadherin, total and phosphorylated (S-897) EphA2, pERK1/2 and MMP2. We also observed that Lupeol in association with Paclitaxel resulted to apoptosis and the disruption of VM associated phenotypes in vitro. We further validated the impact of this novel interventional approach in a patient derived tumor explant culture model of oral malignancy. The ex vivo tumor model mimicked the in vitro anti-VM potential of Lupeol-Paclitaxel combination through down-regulating HIF-1α/EphA2/Laminin-5γ2 cascade. Together, our findings elucidated mechanistic underpinning of hypoxia induced Laminin-5γ2 driven VM formation highlighting that Lupeol-Paclitaxel combination may serve as novel therapeutic intervention in perturbation of VM in human OSCC. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. A biphenyl thiosemicarbazide based fluorogenic chemosensor for selective recognition of Cd2+: application in cell bioimaging.
- Author
-
Biswas, Amitav, Mitra, Debarpan, Naskar, Rahul, Maji, Atanu, Das, Akash, Murmu, Nabendu, and Mondal, Tapan Kumar
- Published
- 2023
- Full Text
- View/download PDF
11. A new "turn-on" molecular switch for idiosyncratic detection of Al3+ ion along with its application in live cell imaging.
- Author
-
Biswas, Amitav, Naskar, Rahul, Mitra, Debarpan, Das, Akash, Gharami, Saswati, Murmu, Nabendu, and Mondal, Tapan Kumar
- Subjects
CELL imaging ,MOLECULAR switches ,FIELD emission ,DENSITY functional theory ,ELECTRONIC structure ,DETECTION limit - Abstract
A highly sensitive, reversible, reusable and fluorogenic "turn-on" probe (HBTC) is fabricated for the sole detection of Al
3+ . On incremental addition of Al3+ in a solution of HBTC in ACN : H2 O (4 : 1), a sharp "turn-on" emission enhancement is observed at 480 nm. The reversibility of the probe (HBTC) was displayed on the addition of F− solution. The detection limit is found to be of the order of 10−9 M which suggests that HBTC can detect Al3+ at a very minute level. The mechanism for Al3+ detection in ACN : H2 O (4 : 1) is attributed to forbidding C=N isomerization and ESIPT process simultaneously turning on the chelation-enhanced fluorescence process. The reusability and real-time application of the probe are also studied. Bioimaging study reveals that HBTC can detect Al3+ in human breast cancer cells (MDA-MB-231). Electronic structure of the probe is explained by density functional theory. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
12. Azophenyl appended Schiff base probe for colorimetric detection of Cu2+ in semi‐aqueous medium and live cell imaging.
- Author
-
Dev, Samrat, Pandey, Souvik, Maity, Suvendu, Mitra, Debarpan, Das, Gaurav, Murmu, Nabendu, and Sinha, Chittaranjan
- Subjects
CELL imaging ,DISCRETE Fourier transforms ,ELECTRON paramagnetic resonance ,COLORIMETRY ,X-ray diffraction measurement ,SCHIFF bases ,FOURIER transforms - Abstract
A phenylazo appended ortho‐vanillin Schiff base scaffold (HAZ) has been used for selective colorimetric sensing of Cu2+ in semi‐aqueous medium (methanol–water, 1:1, v/v) in the presence of 16 cations and 20 anions, and the limit of detection is 1.8 × 10−7 M. The structures of HAZ and Cu (II) complex, [Cu(AZ)2], have been characterised by spectroscopic data (UV–Vis, Fourier transform infrared and electron paramagnetic resonance) and established by the single crystal X‐ray diffraction measurement. The Job's plot from the absorption studies has also confirmed the 1:2 stoichiometry of Cu2+:HAZ. The absorption spectrum of [Cu (AZ)2] has returned to the spectrum of HAZ on the addition of Na2EDTA solution which is again recovered upon the addition of Cu2+ solution. Discrete Fourier transform computations were carried out using the coordinates of the X‐ray structures of the compounds, and the molecular functions were used to correlate the solution spectroscopic properties. In addition to this, the probe is treated on MDA‐MB 231 breast cancer cells to check the cytotoxicity. The probe is used for the detection of trace quantity of Cu2+ in the cancer cell. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
13. Orchestrated expression of vasculogenic mimicry and laminin‐5γ2 is an independent prognostic marker in oral squamous cell carcinoma.
- Author
-
Saha, Depanwita, Mitra, Debarpan, Alam, Neyaz, Sen, Sagar, Mitra Mustafi, Saunak, Mandal, Syamsundar, Majumder, Biswanath, and Murmu, Nabendu
- Subjects
- *
VASCULOGENIC mimicry , *SQUAMOUS cell carcinoma , *PROGNOSIS , *ALCOHOL , *CANCER prognosis , *PROGRESSION-free survival - Abstract
Vasculogenic mimicry (VM), an endothelial cell–independent alternative mechanism of blood supply to the malignant tumour, has long been considered as an adverse prognostic factor in many cancers. The correlation of VM with laminin‐5γ2 and the assessment of their harmonized expression as an independent risk factor have not been elucidated yet in oral squamous cell carcinoma (OSCC). CD31/PAS staining stratified 116 clinically diagnosed OSCC specimens into VM+ and VM− cohorts. The expression pattern of laminin‐5γ2 and its upstream modulator MMP2 was evaluated by immunohistochemistry and Western blot. The Kaplan–Meier and Cox regression analyses were performed to assess the survival and prognostic implications. The presence of VM demonstrated a significant correlation with the expression of laminin‐5γ2 (p <.001) and MMP2 (p <.001). This pattern was mirrored by the significant upregulation of laminin‐5γ2 and MMP2 in VM+ cohorts compared with the VM− ones. Furthermore, co‐expression of VM and laminin‐5γ2 was significantly associated with tumour grade (p =.010), primary tumour size (p <.001), lymph node metastasis (p =.001) and TNM stages (p <.001) but not with patients' age, gender, tobacco and alcohol consumption habit. Vasculogenic mimicry and laminin‐5γ2 double‐positive cohort displayed a significantly poorer disease‐free survival (DFS) and overall survival (OS). Vasculogenic mimicry, laminin‐5γ2 and their subsequent dual expression underlie a significant prognostic value for DFS [hazard ratio (HR) = 9.896, p =.028] and OS [HR = 21.401, p =.033] in OSCC patients. Together, our findings imply that VM along with laminin‐5γ2 is strongly linked to the malignant progression in OSCC and VM and laminin‐5γ2 coordination emerges as a critical prognostic biomarker for OSCC. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
14. Mechanistic Profiling Of Phytochemical As Anti-Cancer Agent Against Multiple Clinically Aggressive Cancers.
- Author
-
Mitra, Debarpan, Majumder, Biswanath, and Majumder, Pradip K.
- Subjects
- *
CANCER stem cells , *CANCER , *PROSTATE cancer , *VASCULOGENIC mimicry , *CELL lines - Abstract
Background: Despite our efforts to develop effective treatment paradigms, the overall success rates of most of the anti-cancer therapies for aggressive cancers remain very low. There is an urgent need to develop novel therapeutics to meet the present challenges. In recent years, several plant derived chemicals showed promising return as antineoplastic agents. Objective: Here, we evaluate the anticancer effects of one well known phytochemical Lupeol on a panel of aggressive cancer types in preclinical platforms. Methods: Melanoma (B16- F10), breast cancer (MDA MB- 231), Cisplatin resistant laryngeal cancer cell line HEp-2c, oral cancer cell line UPCI: SCC131 and prostate cancer (PC-3) cell lines were treated with different doses of Lupeol for 24 and 48 hours. Cytotoxic effects of these agents were measured by different endpoint assays. Matrigel tube formation, Limiting Dilution (LD) and sphere formation assay along with alteration in CD133 expression were performed. The expression status of Ephrin A2 and its downstream molecules were examined in aggressive mouse melanoma solid tumor in vivo. We also established the key findings in a patient derived ex vivo explant model (CANScript TM) for human breast and HNSCC tumors. Results: Viability (MTT) assay showed significant IC50 value for each cell lines treated with Lupeol followed by CFU assay. Concurrently, induction of apoptosis was found to be prominent in treatment arm. We also observed down regulation of CD133 expression and disrupted tube formation in all cell lines that together ascertain their ability to inhibit vasculogenic mimicry (VM). The ability of Lupeol to interfere with cancer stem cell (CSC) like properties was also evident where sphere formation and LD profile demonstrated alteration in the CSC pools for majority. The machinery of these effects suggested its link with Ephrin A2 and its downstream elements driving VM in melanoma in vivo tumour model. Further validation of these data in patient derived CANScript ex vivo setting where efficacy of this drug was tested on the patient tumors clinically progressed on standard of care (SOC). Discussion and conclusion: Together, these data suggest the promising roles of phytochemical in treating diverse cancer indications at aggressive or late stages of the diseases where existing paradigms frequently show limited efficacy. [ABSTRACT FROM AUTHOR]
- Published
- 2017
15. Prediction of anticancer drug response in an adjuvant clinical setting for breast cancers by ex vivo live tumor phenotypic assay platform.
- Author
-
Nath, Partha, Murmu, Nabendu, Mitra, Debarpan, Oliyarashi, Muthusami, Rajappa, Manoj, Mehrotra, Debapriya Ghosh, Radhakrishnan, Padhma, Thiyagarajan, Saravanan, Majumder, Biswanath, and Majhi, Tapas
- Subjects
ANTINEOPLASTIC agents ,BREAST cancer ,PROPHECY ,TECHNICAL reports ,GROWTH factors - Abstract
Basis: Our learning from the limited trajectory of biomarker guided and genomic assay based response prediction to inform clinical action ability of cancers led to the strategic rethinking of developing and validating robust and individualized platform (CANScript) that make prediction based on multiple phenotypic inputs. Methods: Accelerated CANScript Enabled Personalized Treatment (ACCEPT) is an investigator initiated study aiming to predict response to anticancer drugs at clinic. Surgically resected tumors from primary breast cancer patients (n=30) were cultured in slices and treated with Epirubicin, Cyclophosphamide and 5FU in CANScript platform for three days in presence of autologous growth factors, immune milieu and indication specific matrix support where patient tumor microenvironment was extensively preserved. The outcome was measured by integrating both pathological (tumor content, viability, proliferation and induction of apoptosis) and kinetic endpoints (cell viability and metabolism) into a single data trained M score algorithm as described (Majumder B et al., Nature Commun, 2015, Brijwani N et al., Scientific Reports, 2017). After 6 cycles of therapy, following surgery, patients were clinically evaluated for response based on multiple criteria including radiological examination. This short-term clinical response was compared with CANScript driven response prediction. Results: Out of 25 evaluable patients, outcome is available for ten patients (40%) till today. Data indicate that CANScript derived predictive scores for responders and non-responders were highly correlated with clinical observation. For all six clinical non-responders, CANScript guided outcome was found to be matched with clinical outcome. Similarly, for rest 4 patients, while CANScript predicted response, 3 patients showed clinical response. These preliminary data from an ongoing study are encouraging and more patients will be enrolled and follow up data will be collected. Conclusion: Phenotypic assay based platform technologies are emerging as a new frontier of individual response prediction based on the complex and dynamic interplay of tumor and stroma including immune network. CANScript guided prediction of response showed encouraging results to understand the response of drugs at clinic, would offer further opportunity to incorporate phenotypic inputs for informed treatment decision in an adjuvant setting. [ABSTRACT FROM AUTHOR]
- Published
- 2017
16. Prediction Of Anticancer Drug Response In An Adjuvant Clinical Setting For Breast Cancers By Ex Vivo Live Tumor Phenotypic Assay Platform.
- Author
-
Murmu, Nabendu, Mitra, Debarpan, and Oliyarashi, Muthusami
- Subjects
- *
ANTINEOPLASTIC agents , *BREAST cancer , *PROPHECY , *TECHNICAL reports , *GROWTH factors - Abstract
Basis: Our learning from the limited trajectory of biomarker guided and genomic assay based response prediction to inform clinical action ability of cancers led to the strategic rethinking of developing and validating robust and individualized platform (CANScript) that make prediction based on multiple phenotypic inputs. Methods: Accelerated CANScript Enabled Personalized Treatment (ACCEPT) is an investigator initiated study aiming to predict response to anticancer drugs at clinic. Surgically resected tumors from primary breast cancer patients (n=30) were cultured in slices and treated with Epirubicin, Cyclophosphamide and 5FU in CANScript platform for three days in presence of autologous growth factors, immune milieu and indication specific matrix support where patient tumor microenvironment was extensively preserved. The outcome was measured by integrating both pathological (tumor content, viability, proliferation and induction of apoptosis) and kinetic endpoints (cell viability and metabolism) into a single data trained M score algorithm as described (Majumder B et al., Nature Commun, 2015, Brijwani N et al., Scientific Reports, 2017). After 6 cycles of therapy, following surgery, patients were clinically evaluated for response based on multiple criteria including radiological examination. This short-term clinical response was compared with CANScript driven response prediction. Results: Out of 25 evaluable patients, outcome is available for ten patients (40%) till today. Data indicate that CANScript derived predictive scores for responders and non-responders were highly correlated with clinical observation. For all six clinical non-responders, CANScript guided outcome was found to be matched with clinical outcome. Similarly, for rest 4 patients, while CANScript predicted response, 3 patients showed clinical response. These preliminary data from an ongoing study are encouraging and more patients will be enrolled and follow up data will be collected. Conclusion: Phenotypic assay based platform technologies are emerging as a new frontier of individual response prediction based on the complex and dynamic interplay of tumor and stroma including immune network. CANScript guided prediction of response showed encouraging results to understand the response of drugs at clinic, would offer further opportunity to incorporate phenotypic inputs for informed treatment decision in an adjuvant setting. [ABSTRACT FROM AUTHOR]
- Published
- 2017
17. A biphenyl thiosemicarbazide based fluorogenic chemosensor for selective recognition of Cd 2+ : application in cell bioimaging.
- Author
-
Biswas A, Mitra D, Naskar R, Maji A, Das A, Murmu N, and Mondal TK
- Subjects
- Humans, Spectrometry, Fluorescence methods, Ions, Cadmium analysis
- Abstract
A diversified biphenyl thiosemicarbazide based chemosensor (HBMC) has been fabricated and reported for the specific detection of Cd
2+ in a MeOH : H2 O (4 : 1) solution. We observed a chromogenic change from colorless to light yellow colour, and it showed a "turn-on" fluorogenic change from non fluorescent to blooming cyan colour. In fluorometric titration a sharp "turn-on" emission for Cd2+ was observed with a ∼16 fold increase in fluorescence intensity value at 496 nm by incremental addition of Cd2+ ions in the MeOH : H2 O (4 : 1) solution. The reversibility of the chemosensor (HBMC) was confirmed by a sequential addition of the EDTA solution. Again the binding stoichiometry of HBMC with Cd2+ was found to be 2 : 1, as confirmed by Job's plot analysis and HRMS spectra of the HBMC-Cd2+ complex. The mechanism for Cd2+ sensing in MeOH : H2 O (4 : 1) is based upon the inhibition of CN isomerization and ESIPT process and simultaneously turning on the CHEF (chelation enhanced fluorescence) process. The limit of detection for Cd2+ was found to be in the order of 10-8 (M), which implies that HBMC is an efficient probe to detect Cd2+ at the microscopic level. A reusability study was performed and on-sight detection of cadmium ions by the chemosensor (HBMC) was established by dip-stick experiment. In vitro detection of Cd2+ in human breast cancer cells (MDA-MB-231) by HBMC discloses its cell permeability and biocompatible nature. Computational studies (DFT and TDDFT) with the probe HBMC and HBMC-Cd2+ complex were also performed.- Published
- 2023
- Full Text
- View/download PDF
18. Madhuca indica Inhibits Breast Cancer Cell Proliferation by Modulating COX-2 Expression.
- Author
-
Ghosh P, Mitra D, Mitra S, Ray S, Banerjee S, and Murmu N
- Subjects
- Apoptosis drug effects, Breast Neoplasms drug therapy, Breast Neoplasms pathology, Female, Humans, MCF-7 Cells, Plant Extracts chemistry, Breast Neoplasms enzymology, Cell Proliferation drug effects, Cyclooxygenase 2 biosynthesis, Gene Expression Regulation, Enzymologic drug effects, Gene Expression Regulation, Neoplastic drug effects, Madhuca chemistry, Neoplasm Proteins biosynthesis, Plant Extracts pharmacology
- Abstract
Background: Madhuca indica belongs to the family sapotaceae, commonly known as Mahua. It is primarily known for alcoholic beverage production and is reported to have anti-inflammatory, analgesic and antipyretic properties. Madhuca indica has also been reported to be effective in several diseases., Objective: This study was undertaken to check the anticancer efficacy and chemopreventive effect of methanolic extract of Mahua flower (ME) on human breast cancer cell lines MCF-7 and MDA-MB-468., Method: The cytotoxic and anti-proliferative effects on MCF-7 and MDA-MB-468 cells were studied by MTT, hexosaminidase and colony formation assay. Expression of caspase 3/7 was assessed by flow cytometry and western blot analysis. Expression of COX-2 was evaluated by western blot analysis, luciferase assay and mRNA analysis., Results: ME inhibited the proliferation of breast cancer cells by inducing apoptosis through up-regulating the expression of Caspase 3/7 (P < 0.0001). Our results showed a decrease in the expression of COX-2 mRNA and COX-2 protein in both MCF-7 and MDA-MB-468 cells with an increase in ME concentration. Furthermore synergistic effect of ME and chemotherapeutic drug paclitaxel was also studied in MCF-7 and MDA-MB- 468 cells which were found to be more effective (P < 0.0001) than treatment of either ME or paclitaxel alone. Results were analyzed by ANOVA and Pearson correlation analysis., Conclusion: All these experiments suggest that ME inhibits breast cancer cell proliferation and apoptosis by inhibiting the expression of COX-2 in MCF-7 and MDAMB- 468 cells. This work further highlighted that ME may enhance the potentiality of paclitaxel in breast cancer treatment., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.